Prioritizing research: evaluation of a portfolio management approach in clinical
Prioritizing research: evaluation of a portfolio management approach in clinical
批准号:
8755544
负责人:
Caroline Savage Bennette
金额:
$3.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2014-12-14
中文摘要
描述(由申请人提供):目前使用的所有医疗干预措施中,有临床证据支持的不到一半。尽管每年拨款超过110亿美元支持临床研究,但用于医学研究的联邦资金缺乏一个协调的系统来优先考虑和分配资源,以有效地解决这些重要的知识差距。因此,如果要将有限的公共资金用于可能对公共卫生产生最大影响的方式,一个优先考虑最有希望的临床研究的协调系统至关重要。投资组合管理是一种系统的决策方法,在私营部门广泛用于通知和管理研究投资。本提案的总体目标是确定投资组合管理框架是否可以提高在大型癌症环境中选择和优先考虑公共资助研究的效率
英文摘要
DESCRIPTION (provided by applicant): Fewer than half of all medical interventions in use today are supported by clinical evidence. Despite allocating more than $11 billion each year to support clinical research, federal funding for medical research lacks a coordinated system for prioritizing and allocating resources to efficiency address these important knowledge gaps. Thus a coordinated system to prioritize the most promising clinical research is critical if limited publc funds are to be used in ways that are likely to have the greatest impact on public health. Portfolio management is a systematic approach to decision-making that is widely used in the private sector to inform and manage research investments. The overall objective of this proposal is to determine whether a portfolio management framework can improve the efficiency of selecting and prioritizing publicly funded research studies within the setting of a large cancer
clinical trials cooperative group. The key challenge to implementing such a framework in the public research setting is the difficultly in defining and efficiently estimating two key measures f performance the expected risk of failure and the expected societal return from the proposed research study. The aims of this proposal are therefore to develop and evaluate quantitative metrics of risk and return that are appropriate for the publicly funded clinical trial setting and relevant to and accepted by stakeholders. We will develop a statistical model to predict the risk of a clinical trial failure, defined as a trial that does not enroll a sufficient number of patient and consequently is unable to inform clinical practice patterns, based on trial-level variables available before the trial is launched. We will quantify the societal return of the proposed studie using Value of Information (VOI) analyses and will develop a process for rapidly and efficiently generating these estimates using a relatively new technique, minimal modeling VOI. Lastly, we will estimate measures of risk and return for a sample of recently reviewed clinical trial proposals to illustrate how a portfolio management framework can improve the efficiency of funding decisions within a cancer clinical trials cooperative group setting. Developing measures of risk and return will provide decision makers with valuable information on the study proposals they review and help them make more systematic and efficient funding decisions. If successful, this project could provide a novel prioritization paradigm for medical research organizations and funding agencies, and ultimately help maximize the public health impact of limited research funds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Research on Quantum Field Theory without a Lagrangian Description
-
批准号:24ZR1403900
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:SATOSHI NAWATA
-
依托单位:
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
-
批准号:82371631
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:卢慕峻
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
Lienard系统的不变代数曲线、可积性与极限环问题研究
-
批准号:12301200
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:钱欣洁
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位: